Aim The aim of this systematic review is to summarize all available data on the effect of a
geriatric assessment in older patients with cancer, for oncologic treatment decisions, the …

Aim The aim of this systematic review is to summarise all available data on the effect of a
geriatric evaluation on the multidisciplinary treatment of older cancer patients, focussing on …

Importance Although geriatric assessment–driven intervention improves patient-centered
outcomes, its influence on chemotherapy-related toxic effects remains unknown. Objective …

Purpose To provide guidance regarding the practical assessment and management of
vulnerabilities in older patients undergoing chemotherapy. Methods An Expert Panel was …

As the majority of patients with cancer are older than 65 years, most medical, surgical, and
radiation oncologists treat a large number of older adults in their clinical practice. Older …

Background The median age of prostate cancer diagnosis is 66 years, and the median age
of men who die of the disease is eighty years. The public health impact of prostate cancer is …

Despite substantial improvements in the outcomes of patients with cancer over the past two
decades, older adults (aged≥ 65 years) with cancer are a rapidly increasing population and …

Cancer is a major cause of morbidity and mortality for older individuals. Palliative care is
essential to improve the outcome of cancer treatment in terms of quality of life and treatment …

Purpose Family members are a part of the team to improve the outcomes of the person with
cancer. Families require support and information to optimise their care, however, their needs …

Cancer is primarily a disease of aging, and the majority of new diagnoses of cancer occur in
patients $65 years of age (herein referred to as older). 1 At the same time, cancer and its …